Association of gliclazide and left ventricular mass in type 2 diabetic patients

Nan Hung Pan, Tsung-Ming Lee, Mei S. Lin, Chen-Ling Huang, Nen Chung Chang

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)


Diabetes is a state of increased oxidant stress and there is evidence that oxidation may play a role in the genesis of higher left ventricular mass. Gliclazide has been shown to possess free radical scavenging properties. We assessed whether gliclazide may have a beneficial effect on left ventricular mass via reducing 8-iso-prostaglandin F concentrations, a reliable marker of oxidant injury. A total of 41 patients were randomized into two groups. All patients had been taking glibenclamide for more than 3 months before being randomized to switch either an equipotent dose of gliclazide (n = 21) or to continue on glibenclamide (n = 20). Baseline characteristics were similar in both groups. At 6 months, gliclazide-treated patients showed a significant regression in left ventricular mass index compared with the glibenclamide-treated group (-16% versus 3%, P = 0.003). Gliclazide patients had significantly lower plasma 8-iso-prostaglandin F compared with baseline (299 ± 101 pg/ml versus 400 ± 112 pg/ml, P = 0.001) and the glibenclamide-treated patients (299 ± 101 pg/ml versus 388 ± 114 pg/ml, P = 0.01) after 6-month therapy. The magnitude of left ventricular mass index regression correlated univariately with the magnitude of inhibition of 8-iso-prostaglandin F formation (r = 0.74, P <0.0001). Multivariate analysis revealed that regression of left ventricular mass index significantly correlated with the changes of 8-iso-prostaglandin F (P <0.0001, adjusted R2 = 0.55). Our findings demonstrated for the first time that in addition to its primary hypoglycemia, gliclazide may have an additional effect on reducing left ventricular mass, possibly through attenuation of free radical formation.

Original languageEnglish
Pages (from-to)121-128
Number of pages8
JournalDiabetes Research and Clinical Practice
Issue number2
Publication statusPublished - Nov 2006


  • 8-Iso-prostaglandin F
  • Diabetes mellitus
  • Glibenclamide
  • Gliclazide
  • Left ventricular mass

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Association of gliclazide and left ventricular mass in type 2 diabetic patients'. Together they form a unique fingerprint.

Cite this